Back to Search
Start Over
Role of Granulocyte-Macrophage Colony-Stimulating Factor Production by T Cells during Mycobacterium tuberculosis Infection.
- Source :
-
MBio [mBio] 2017 Oct 24; Vol. 8 (5). Date of Electronic Publication: 2017 Oct 24. - Publication Year :
- 2017
-
Abstract
- Mice deficient for granulocyte-macrophage colony-stimulating factor (GM-CSF <superscript>-/-</superscript> ) are highly susceptible to infection with Mycobacterium tuberculosis , and clinical data have shown that anti-GM-CSF neutralizing antibodies can lead to increased susceptibility to tuberculosis in otherwise healthy people. GM-CSF activates human and murine macrophages to inhibit intracellular M. tuberculosis growth. We have previously shown that GM-CSF produced by iNKT cells inhibits growth of M. tuberculosis However, the more general role of T cell-derived GM-CSF during infection has not been defined and how GM-CSF activates macrophages to inhibit bacterial growth is unknown. Here we demonstrate that, in addition to nonconventional T cells, conventional T cells also produce GM-CSF during M. tuberculosis infection. Early during infection, nonconventional iNKT cells and γδ T cells are the main source of GM-CSF, a role subsequently assumed by conventional CD4 <superscript>+</superscript> T cells as the infection progresses. M. tuberculosis -specific T cells producing GM-CSF are also detected in the peripheral blood of infected people. Under conditions where nonhematopoietic production of GM-CSF is deficient, T cell production of GM-CSF is protective and required for control of M. tuberculosis infection. However, GM-CSF is not required for T cell-mediated protection in settings where GM-CSF is produced by other cell types. Finally, using an in vitro macrophage infection model, we demonstrate that GM-CSF inhibition of M. tuberculosis growth requires the expression of peroxisome proliferator-activated receptor gamma (PPARγ). Thus, we identified GM-CSF production as a novel T cell effector function. These findings suggest that a strategy augmenting T cell production of GM-CSF could enhance host resistance against M. tuberculosis IMPORTANCE Mycobacterium tuberculosis is the bacterium that causes tuberculosis, the leading cause of death by any infection worldwide. T cells are critical components of the immune response to Mycobacterium tuberculosis While gamma interferon (IFN-γ) is a key effector function of T cells during infection, a failed phase IIb clinical trial and other studies have revealed that IFN-γ production alone is not sufficient to control M. tuberculosis In this study, we demonstrate that CD4 <superscript>+</superscript> , CD8 <superscript>+</superscript> , and nonconventional T cells produce GM-CSF during Mycobacterium tuberculosis infection in mice and in the peripheral blood of infected humans. Under conditions where other sources of GM-CSF are absent, T cell production of GM-CSF is protective and is required for control of infection. GM-CSF activation of macrophages to limit bacterial growth requires host expression of the transcription factor PPARγ. The identification of GM-CSF production as a T cell effector function may inform future host-directed therapy or vaccine designs.<br /> (Copyright © 2017 Rothchild et al.)
- Subjects :
- Animals
Granulocyte-Macrophage Colony-Stimulating Factor genetics
Humans
Interferon-gamma biosynthesis
Interferon-gamma immunology
Lung immunology
Lung microbiology
Macrophages immunology
Macrophages microbiology
Mice
PPAR gamma metabolism
Tuberculosis prevention & control
CD4-Positive T-Lymphocytes immunology
CD8-Positive T-Lymphocytes immunology
Granulocyte-Macrophage Colony-Stimulating Factor biosynthesis
Granulocyte-Macrophage Colony-Stimulating Factor immunology
Mycobacterium tuberculosis immunology
T-Lymphocyte Subsets immunology
Tuberculosis immunology
Subjects
Details
- Language :
- English
- ISSN :
- 2150-7511
- Volume :
- 8
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- MBio
- Publication Type :
- Academic Journal
- Accession number :
- 29066547
- Full Text :
- https://doi.org/10.1128/mBio.01514-17